Market closedNon-fractional
BioLife Solutions/BLFS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About BioLife Solutions
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in developing, manufacturing, and marketing a portfolio of biopreservation tools and services for cells, tissues, and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
Ticker
BLFS
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Bothell, United States
Employees
-
Website
www.biolifesolutions.com
BLFS Metrics
BasicAdvanced
$1.1B
Market cap
-
P/E ratio
-$1.42
EPS
1.69
Beta
-
Dividend rate
Price and volume
Market cap
$1.1B
Beta
1.69
Financial strength
Current ratio
2.889
Quick ratio
1.652
Long term debt to equity
8.86
Total debt to equity
8.86
Interest coverage (TTM)
-33.92%
Management effectiveness
Return on assets (TTM)
-8.04%
Return on equity (TTM)
-18.20%
Valuation
Price to revenue (TTM)
7.434
Price to book
3.14
Price to tangible book (TTM)
3.14
Price to free cash flow (TTM)
-46.349
Growth
Revenue change (TTM)
-15.89%
Earnings per share change (TTM)
-58.45%
3-year revenue growth (CAGR)
37.54%
3-year earnings per share growth (CAGR)
28.90%
What the Analysts think about BLFS
Analyst Ratings
Majority rating from 9 analysts.
BLFS Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$32M
-3.06%
Net income
-$10M
-23.31%
Profit margin
-32.17%
-20.90%
BLFS Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.23
-$0.67
-$0.30
-$0.23
-
Expected
-$0.20
-$0.38
-$0.34
-$0.28
-$0.14
Surprise
15.00%
78.67%
-12.20%
-17.86%
-
BLFS News
AllArticlesVideos
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024
PRNewsWire·1 day ago
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
PRNewsWire·2 months ago
BioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call Transcript
Seeking Alpha·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BioLife Solutions stock?
BioLife Solutions (BLFS) has a market cap of $1.1B as of July 27, 2024.
What is the P/E ratio for BioLife Solutions stock?
The price to earnings (P/E) ratio for BioLife Solutions (BLFS) stock is 0 as of July 27, 2024.
Does BioLife Solutions stock pay dividends?
No, BioLife Solutions (BLFS) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next BioLife Solutions dividend payment date?
BioLife Solutions (BLFS) stock does not pay dividends to its shareholders.
What is the beta indicator for BioLife Solutions?
BioLife Solutions (BLFS) has a beta rating of 1.69. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell BioLife Solutions stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.